INSY
Insys Therapeutics, Inc.
INSY
INSY
Delisted
INSY was delisted on the 18th of June, 2019.
98 hedge funds and large institutions have $51.6M invested in Insys Therapeutics, Inc. in 2019 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 27 increasing their positions, 18 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
45% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 29
Holders
98
Holding in Top 10
–
Calls
$724K
Puts
$1.24M
Top Buyers
| 1 | +$3.03M | |
| 2 | +$2.65M | |
| 3 | +$1.23M | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$672K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$468K |
Top Sellers
| 1 | -$5.08M | |
| 2 | -$2.19M | |
| 3 | -$866K | |
| 4 |
BlackRock
New York
|
-$531K |
| 5 |
JPMorgan Chase & Co
New York
|
-$353K |